1. Home
  2. XBIO vs AUUD Comparison

XBIO vs AUUD Comparison

Compare XBIO & AUUD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xenetic Biosciences Inc.

XBIO

Xenetic Biosciences Inc.

HOLD

Current Price

$2.75

Market Cap

6.9M

Sector

Health Care

ML Signal

HOLD

Logo Auddia Inc.

AUUD

Auddia Inc.

HOLD

Current Price

$1.29

Market Cap

7.1M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
XBIO
AUUD
Founded
N/A
2012
Country
United States
United States
Employees
2
5
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
6.9M
7.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
XBIO
AUUD
Price
$2.75
$1.29
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
13.9K
263.1K
Earning Date
05-13-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2.81
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.90
$0.51
52 Week High
$13.93
$10.10

Technical Indicators

Market Signals
Indicator
XBIO
AUUD
Relative Strength Index (RSI) 53.16 45.15
Support Level $2.89 $1.15
Resistance Level $3.25 $1.47
Average True Range (ATR) 0.17 0.09
MACD 0.01 0.02
Stochastic Oscillator 73.80 39.51

Price Performance

Historical Comparison
XBIO
AUUD

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immuno-oncology technologies addressing difficult-to-treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors. Its product pipeline consists of two key programs, XBIO-015 and XBIO-020, which are being developed to address pancreatic carcinoma and solid tumours.

About AUUD Auddia Inc.

Auddia Inc is a United States-based company. It operates through its proprietary AI platform for audio and is reinventing not only how consumers engage with AM/FM radio, podcasts, and other audio content but also how artists and labels promote their music and gain access to mainstream radio audiences. The group Discovr Radio is the first music-promotion platform to deliver artists guaranteed exposure to radio listeners. Its flagship audio superapp, called faidr, delivers multiple industry firsts, including: Ad-free listening on any AM/FM radio station, Content skipping across any AM/FM station, One-touch skipping of entire podcast ad breaks, and Integrated artist discovery experiences.

Share on Social Networks: